
Following our announcement on
Elections for the scrip dividend alternative must be received by the deadlines specified in the timetable below.
The scrip dividend alternative will involve the issuance of relevant new ordinary shares on the
The scrip dividend alternative is offered in addition to the Dividend Reinvestment Plan (DRIP), which continues to be available to shareholders on the
2024 first interim dividend timetable (scrip dividend alternative and DRIP)
Ex-dividend date |
|
Record date |
|
Announcement of scrip reference price(1) |
|
Expected publication of scrip dividend circular and mandate forms |
On or around |
Deadline for receipt of scrip elections |
|
Deadline for receipt of Dividend Re-investment Plan elections |
|
Payment date, where cash dividends are paid and scrip shares are issued (other than scrip shares to be sold under the Dealing Facility) |
On or around |
Notes:
(1) The price used to calculate the number of new ordinary shares offered under the scrip dividend alternative is the average middle-market price of the shares of Prudential on the
(2) The latest time for returning the mandate form by
(3) Currency election details were announced on
(4) All shares bought back by Prudential awaiting cancellation on the Record Date are not eligible for the 2024 first interim dividend.
Shares held on the
On
Elections via CREST should be received by Computershare no later than
An election via CREST will not apply in respect of future dividends.
Contacts
Media |
|
Investors/Analysts |
|
|
+44 (0)7581 023260 |
|
+852 9611 2981 |
|
+852 5580 7525 |
|
+44 (0)20 3977 9215 |
|
|
|
+852 2918 6348 |
About
Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in
The ISIN code for the ordinary shares of Prudential is GB0007099541 and the TIDM code is PRU.
https://www.prudentialplc.com/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the